By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Merz Pharmaceuticals, LLC 

Post Office Box 18806

Greensboro  North Carolina  27419   U.S.A.
Phone: 888-MERZ-USA or 888-637-9872 Fax: 336-856-0107


SEARCH JOBS


Industry
Pharmaceutical






Company News
CAIDE Looks Into The Future: New App From Merz Pharmaceuticals, LLC Assesses The Risk Of Getting Dementia Within The Next 20 Years 8/29/2014 11:31:46 AM
Merz Pharmaceuticals, LLC Release: Mederma® Wear Your Skin Proudly™ Survey Reveals Men and Women have Complex and Often Differing Feelings About How Their Skin Imperfections Impact their Appearance and Confidence 2/21/2013 10:09:04 AM
Allergan Inc. (AGN) Comments on Order Regarding Permanent Injunction Against Merz Pharmaceuticals, LLC and Merz Aesthetics (Formerly Known as BioForm Medical, Inc.) 10/2/2012 9:55:57 AM
Merz Pharmaceuticals, LLC Introduces New Mederma® Advanced Scar Gel 3/19/2012 10:11:36 AM
U.S. Federal Court Finds in Favor of Allergan Inc. (AGN) and Issues Permanent Injunction Against Merz Pharmaceuticals, LLC and Merz Aesthetics (Formerly Known as BioForm Medical, Inc.) 3/12/2012 7:30:36 AM
Merz Pharmaceuticals, LLC Receives J-Code For Xeomin(R) (incobotulinumtoxinA) 1/4/2012 1:29:53 PM
Merz Pharmaceuticals, LLC Release: XEOMIN(R) (IncobotulinumtoxinA) Data to be Presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation 11/18/2011 9:33:11 AM
Merz Pharmaceuticals, LLC Release: Data on Xeomin(R) (incobotulinumtoxinA) in the Treatment of Blepharospasm to be Presented at the 115th Annual Meeting of the American Academy of Ophthalmology 10/25/2011 11:57:42 AM
Merz Pharmaceuticals, LLC Research Shows Long-term Benefits for Patients With Dystonia 10/21/2011 12:39:39 PM
Merz Pharmaceuticals, LLC Commends The Benign Essential Blepharospasm Research Foundation On 30 Years Of Community Support 7/22/2011 10:06:22 AM
12345
//-->